Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04113226
Title Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma (Relyage)
Acronym Relyage
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire, Amiens
Age Groups: senior
Covered Countries FRA

No variant requirements are available.